Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aytu, Beigene, Biogen, Biosig, BMS, Brightinsight, Cannabics, Cansino, Celgene, Cold Genesys, Debiopharm, F. Hoffmann-La Roche, Forge, Immuron, Laekna, Lidds, Mateon, Novartis, PCI. 3B, Redhill, Repertoire, Sorrento, Stemcell, Turn, Vir, Wuxi.